Dietary supplementation with (R)-α-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex

Redox Report

Volumn 10, Issue 1, 2005, Pages 52-60

  Suh, Jung H ^a   Moreau, Régis ^a   Heath, Shi Hua D ^a   Hagen, Tory M ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

(R) lipoic acid; Antioxidant depletion; Chronic oxidative stress; Iron accumulation

Indexed keywords

ANTIOXIDANT; CHELATING AGENT; GLUTATHIONE; IRON; THIOCTIC ACID; THIOL;

ANIMAL TISSUE; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BRAIN CORTEX; CONTROLLED STUDY; DIET SUPPLEMENTATION; IN VITRO STUDY; IRON DEPLETION; MALE; MITOCHONDRION; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; RAT;

AGING; ANIMALS; ANTIOXIDANTS; BRAIN; CEREBRAL CORTEX; DIETARY SUPPLEMENTS; IRON; MALE; RATS; RATS, INBRED F344; THIOCTIC ACID;

ANIMALIA;

EID: 27644516440     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100005X21624     Document Type: Article

References (42)

1. Cook CI, Yu BP. Iron accumulation in aging: modulation by dietary restriction. Mech Ageing Dev 1998; 102: 1-13.
2. Zecca L, Gallorini M, Schunemann V et al. Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J Neurochem 2001; 76: 1766-1773.
3. Eaton JW, Qian M. Molecular bases of cellular iron toxicity. Free Radic Biol Med 2002; 32: 833-840.
4. Floor E. Iron as a vulnerability factor in nigrostriatal degeneration in aging and Parkinson's disease. Cell Mol Biol (Noisy-le-grand) 2000; 46: 709-720.
5. Perl DP, Good PF. Comparative techniques for determining cellular iron distribution in brain tissues. Ann Neurol 1992; 32: S76-S81.
6. Youdim MB, Ben-Shachar D, Yehuda S, Riederer P. The role of iron in the basal ganglion. Adv Neurol 1990; 53: 155-162.
7. Gerlach M, Ben-Shachar D, Yehuda S, Riederer P. The role of brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 1994; 63: 793-807.
8. Smith MA, Harris PL, Sayre LM, Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 1997; 94: 9866-9868.
9. Chiueh CC, Wu RM, Mohanakumar KP et al. In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia. Ann NY Acad Sci 1994; 738: 25-36.
10. Schipper HM, Cisse S. Mitochondrial constituents of corpora amylacea and autofluorescent astrocytic inclusions in senescent human brain. Glia 1995; 14: 55-64.
11. Atamna H, Killilea DW, Killilea AN, Ames BN. Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging. Proc Natl Acad Sci USA 2002; 99: 14807-14812.
12. Benzi G, Pastoris O, Marzatico F, Villa RF. Age-related effect induced by oxidative stress on the cerebral glutathione system. Neurochem Res 1989; 14: 473-481.
13. Reiter RJ. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J 1995; 9: 526-533.
14. Rice ME, Russo-Menna I. Differential compartmentalization of brain ascorbate and glutathione between neurons and glia. Neuroscience 1998; 82: 1213-1223.
15. Rice ME. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci 2000; 23: 209-216.
16. Andersen O, Aaseth J. Molecular mechanisms of in vivo metal chelation: implications for clinical treatment of metal intoxications. Environ Health Perspect 2002; 110 (Suppl 5): 887-890.
17. Hershko C, Weatherall DJ. Iron-chelating therapy. Crit Rev Clin Lab Sci 1998; 26: 303-305.
18. Chiueh CC. Iron overload, oxidative stress, and axonal dystrophy in brain disorders. Pediatr Neurol 2001; 25: 138-147.
19. Reed LJ. A trail of research from lipoic acid to alpha-keto acid dehydrogenase complexes. J Biol Chem 2001; 276: 38329-38336.
20. Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med 1997; 22: 359-378.
21. Suh JH, Shenvi SV, Dixon BM et al. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci USA 2004; 101: 3381-3386.
22. Suh JH, Shigeno ET, Morrow JD et al. Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acid. Antioxid Redox Signal 2000; 2: 473-483.
23. Hagen TM, Vinarsky V, Wehr CM, Ames BN. (R)-alpha-lipoic acid reverses the age-associated increase in susceptibility of hepatocytes to tert-butylhydroperoxide both in vitro and in vivo. Antioxid Redox Signal 2000; 2: 473-483.
24. Suh JH, Zhu BZ, deSzoeke E, Frei B, Hagen TM. Dihydrolipoic acid lowers the redox activity of transition metal ions but does not remove them from the active site of enzymes. Redox Report 2004; 9: 57-61.
25. Matsugo S, Yan LJ, Han D, Trischler HJ, Packer L. Elucidation of antioxidant activity of alpha-lipoic acid toward hydroxyl radical. Biochem Biophys Res Commun 1995; 208: 161-167.
26. Goralska M, Dackor R, Holley B, McGahan MC. Alpha lipoic acid changes iron uptake and storage in lens epithelial cells. Exp Exe Res 2003; 76: 241-248.
27. Anderson MF, Sims NR. Improved recovery of highly enriched mitochondrial fractions from small brain tissue samples. Brain Res Brain Res 2000; 5: 95-101.
28. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 1989; 86: 6377-6381.
29. Jones DP, Carlson JL, Samiec PS et al. Glutathione measurement in human plasma. Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin Chim Acta 1998; 275: 175-184.
30. Raps SP, Lai JC, Hertz L, Cooper AJ. Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons. Brain Res 1986; 493
31. Miyajima H. Aceruloplasminemia, an iron metabolic disorder. Neuropathology 2003; 23: 345-350.
32. Kawabata T, Yap SC, Packer L. The short-chain homologue of dihydrolipoic acid, tetranordihydrolipoate, protects against iron-induced lipid peroxidation in the aqueous phase. Biochem Biophys Res Commun 1994; 199: 361-367.
33. Ou P, Tritschler HJ, Wolff SP. Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? Biochem Pharmacol 1995; 50: 123-126.
34. Connor JR, Menzies SL, St Martin SM, Mufson EJ. Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res 1990; 27: 595-611.
35. Blomquist E, Fredriksson BA, Brunk U. Electron probe X-ray microanalysis of residual bodies in aged cultured human glial cells. Ultrasound Pathol 1980; 1: 11-17.
36. Terman A, Dalen H, Eaton JW, Neuzil J, Brunk UT. Mitochondrial recycling and aging of cardiac myocytes: the role of autophagocytosis. Exp Gerontol 2003; 38: 863-876.
37. Brunk UT, Terman A. The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem 2002; 269: 1996-2002.
38. Persson HL, Svensson AI, Brunk UT. Alpha-lipoic acid and alpha-lipoamide prevent oxidant-induced lysosomal rupture and apoptosis. Redox Report 2001; 6: 327-334.
39. Gonzalez-Perez O, Gonzalez-Castaneda RE, Huerta M et al. Beneficial effects of alpha-lipoic acid plus vitamin E on neurological deficit, reactive gliosis and neuronal remodeling in the penumbra of the ischemic rat brain. Neurosci Lett 2002; 32: 100-104.
40. McGahon BM, Martin DS, Horrobin DF, Lynch MA. Age-related changes in LTP and antioxidant defenses are reversed by an alpha-lipoic acid-enriched diet. Neurobiol Aging 1999; 20: 655-664.
41. Roy S, Sen CK, Tritschler HJ, Packer L. Modulation of cellular reducing equivalent homeostasis by alpha-lipoic acid. Mechanisms and implications for diabetes and ischemic injury. Biochem Pharmacol 1997; 53: 393-399.
42. Han D, Handelman G, Marcocci L et al. Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. Biofactors 1997; 6: 321-338.